KIRST HERBERT | Lilly Research Laboratories, Eli Lilly and Company
スポンサーリンク
概要
Lilly Research Laboratories, Eli Lilly and Company | 論文
- 1日2回投与法によるリスプロ混合製剤-25およびリスプロ混合製剤-50の1型および2型糖尿病患者のQOLに与える影響
- Glycopeptide Carboxamides Active against Vancomycin-resistant Enterococci
- Novel Glycopeptide Antibiotics: N-Alkylated Derivatives Active Against Vancomycin-Resistant Enterococci
- Tripeptide LY301621 and Its Diastereomers as Methicillin Potentiators against Methicillin Resistant Staphylococcus aureus
- Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity